News
Anna Veiga: ”We need very safe iPS cells if we want to use them in the clinic”
The researcher of the Center for Regenerative Medicine in Barcelona, CMR[B], Anna Veiga, explained the latest developments of her research group on “in vitro” models of pluripotency in embryonic stem cells (hESCs) and iPS cells ( induced pluripotent stem cells). It was on January 13 in the cycle of seminars IDIBELL. Since 2005 Veiga directs […]
Manel Esteller, International Research Award of Fundación Dexeus, Women’s Health
Manel Esteller, director of the Epigenetics and Cancer Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor has been awarded with the International Research Award of Fundación Dexeus, Women’s Health in its eighth edition. The award honors a person whose career and continuing line of research constitutes a […]
The program Stromalign receives 1.5 million Euros from the European Research Council
The European Research Council (ERC) has awarded with a Starting Grant for scientific excellence Oriol Casanovas, researcher at IDIBELL and at the Catalan Institute of Oncology for the project ‘Mechanisms and Targeting Stromal Tumor Invasion Contribution tone and Metastasis’. The funded project, called Stromalign, focuses on the study of tumor stroma as a possible major […]
IDIBELL edits a calendar of world health awareness days
Bellvitge Biomedical Research Institute (IDIBELL) has published a calendar that includes the world health awareness days established by the World Health Organization and other international institutions. The calendar expresses IDIBELL’s will to guide its research activities on improving people’s health.
Luis Pérez-Jurado, ”losartan gives good results for treating heart problems in Williams-Beuren syndrome”
Losartan, a drug used against high blood pressure, is an effective treatment for cardiac complications of the cardiovascular phenotype of Williams-Beuren syndrome. This is the result of a recent clinical trial coordinated by the researcher Luis Pérez-Jurado, of the University Pompeu Fabra University and CIBER of Rare Diseases. Pérez-Jurado spoke about the study and the […]
IDIBELL researcher Manel Esteller, elected Academician of the Spanish Royal Academy of Pharmacy
Manel Esteller, director of the Cancer Epigenetics and Biology program of IDIBELL, ICREA research professor and associate professor at the University of Barcelona, has been elected as a new Academician of the Spanish Royal Academy of Pharmacy on December 14th. The Royal Academy of Pharmacy, which dates back to 1589, is a public scientific society […]
IDIBELL Administration begins the process for ISO 9001 certification
IDIBELL’s administrative area has begun process of implementation to be certified by ISO 9001 standard. The project is being coordinated by the Quality Direction and involves all the institution’s administrative departments: Purchasing Contract, Accounting, Human Resources, IT, Prevention, General Services and Maintenance and TTO. The certification obtaining is scheduled for December 2012. IDIBELL’s bet to […]
Presented certificates of IDIBELL summer internships
On December 2nd was held the awarding of diplomas to the ten students who have completed the summer internship at IDIBELL. The event was chaired by the Director General of IDIBELL, Emilià Pola. Also attending the scientific director, Gabriel Capellà, the scientific deputy director, Marga Nadal and the researchers Isabel Fabregat, Cristina Muñoz-Pinedo, Merce Perez, […]
Jordi Sunyer: “Our prenatal environment is fundamental in our mental development”
Air pollution is one of the most common environmental hazards that affect up to 100% of the population from birth to death. The co-director of CREAL (Centre for Research in Environmental Epidemiology), Jordi Sunyer, explained in the seminar series IDIBELL his research in this field. Several studies have shown that environmental exposures and nutrition during […]